Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China
Authors:
- 1 May 2006
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 87 (5) , 1181-1188
Abstract
Human papillomavirus type 16 (HPV16) has a number of intratypic variants; each has a different geographical distribution and some are associated with enhanced oncogenic potential. Cervical samples were collected from 223 cervical cancer patients and from 196 age-matched control subjects in China. DNA samples were amplified by using primers specific for the E6, E7 and partial L1 regions. Products were sequenced and analysed. It was found by using a PCR–sequence-based typing method that HPV infection rates in China were 92·8 % in cervical cancer patients and 15·8 % in healthy controls. HPV16 was detected in 70·4 % of cervical cancer patients and in 6·1 % of controls. In HPV16-positive cervical cancers, 23·6 % belonged to the prototype, 65·5 % were of the Asian variant, 5·5 % were of African type 1 and 3·6 % were European variants, whilst only one was a new variant that differed from any variant published so far. Prevalences of HPV16 E6 D25E and E113D variants were 67·3 and 9 %, respectively. In addition to D25E and E113D, the following E6 variations were found in this study: R129K, E89Q, S138C, H78Y, L83V and F69L. The results also showed that the prevalences of three hot spots of E7 nucleotide variation, N29S, S63F and a silent variation, nt T846C, were 70·2 % (33/47), 51·1 % (24/47) and 61·7 % (29/47), respectively. The following L1 variations were found in this study: S377A, K387E, E378D, K382E and T379P. It was also found that the average age of Asian variant-positive cervical cancer patients (42·98±10·43 years) was 7·56 years lower than that of prototype-positive patients (50·54±10·91). It is suggested that the high frequency of HPV16 Asian variants might contribute to the high incidence of cervical cancer in China.Keywords
This publication has 35 references indexed in Scilit:
- Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The NetherlandsGynecologic Oncology, 2004
- Human Papillomavirus Type 16 Intratypic Variant Infection and Risk for Cervical Neoplasia in Southern ChinaThe Journal of Infectious Diseases, 2002
- Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control StudyJNCI: Journal of the National Cancer Institute, 2001
- Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesionsBritish Journal of Cancer, 2000
- Histologic and Immunologic Associations of an HPV16 Variant in LoSIL SmearsGynecologic Oncology, 1999
- HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variantsInternational Journal of Cancer, 1998
- Human Papillomavirus Variants: Implications for Natural History Studies and Vaccine Development EffortsJNCI: Journal of the National Cancer Institute, 1997
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasiasVirus Genes, 1994
- Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16Journal of General Virology, 1992